Terra, Lara; Hooning, Maartje J; Heemskerk-Gerritsen, Bernadette A M; van Beurden, Marc; Roeters van Lennep, Jeanine E; van Doorn, Helena C; de Hullu, Joanne A; Mom, Constantijne; van Dorst, Eleonora B L; Mourits, Marian J E; Slangen, Brigitte F M; Gaarenstroom, Katja N; Zillikens, M Carola; Leiner, Tim; van der Kolk, Lizet; Collee, Margriet; Wevers, Marijke; Ausems, Margreet G E M; van Engelen, Klaartje; Berger, Lieke Pv; van Asperen, Christi J; Gomez-Garcia, Encarna B; van de Beek, Irma; Rookus, Matti A; Hauptmann, Michael; Bleiker, Eveline M; Schagen, Sanne B; Aaronson, Neil K; Maas, Angela H E M; van Leeuwen, Flora E
(JMIR Publications Inc., 2021-01-22)
Background: BRCA1/2 mutation carriers are recommended to undergo risk-reducing salpingo-oophorectomy (RRSO) at 35 to 45 years of age. RRSO substantially decreases ovarian cancer risk, but at the cost of immediate menopause. ...